PLOS One · 20 Nov 2026
Dermal α-synuclein seeding in relation to REM sleep behavior disorder across prodromal and Parkinson disease cohorts
Emadoddin Kazemih-index 1
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
REM sleep behavior disorder (RBD) is a well-established prodromal manifestation of synucleinopathy and is closely linked to peripheral clinical features in Parkinson disease (PD). Dermal α-synuclein seed amplification assay (SAA) provides a peripheral measure of pathological α-synuclein across these disease stages. We performed a cross-sectional analysis of data from the Parkinson’s Precision Medicine Initiative (PPMI), including controls, participants with polysomnography-confirmed RBD, and participants with PD. Skin SAA positivity and participant-level kinetic measures (area under the curve [AUC], maximum fluorescence [Fmax], and time to threshold [TTT]) were assessed at 1:20 and 1:50 lysate dilutions. Participants with PD were further classified as suspected brain/motor-enriched or body/peripheral-enriched based on prespecified exploratory clinical features. Skin SAA positivity was detected in 53.3% of participants with polysomnography-confirmed RBD compared with none of the controls, and RBD participants showed significantly faster amplification than controls at both lysate dilutions. Within PD, binary SAA positivity was higher in the suspected body/peripheral-enriched than brain/motor-enriched phenotype, but the difference was not statistically significant (83.3% vs 47.6%; p = 0.067). All seven kinetic measures were greater in the suspected body/peripheral-enriched phenotype after false discovery rate correction, but these differences were not retained when RBDSQ total score was removed from the classification. RBDSQ total score was the only clinical variable associated with skin SAA kinetics after correction and was significantly associated with six of the seven kinetic measures. These findings show that dermal α-synuclein seeding is detectable in PSG-confirmed prodromal RBD and is associated with RBD-related clinical features within established PD.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Emadoddin Kazemi has the highest h-index among the authors (1).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (19)
What it cites, from open citation data, with Crossref's record of each.